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Abstract
Background: Clostridium difficile can cause antibiotic-associated diarrhea and a possibility of outbreaks in hospital
settings warrants molecular typing. A microarray was designed that included toxin genes (tcdA/B, cdtA/B), genes
related to antimicrobial resistance, the slpA gene and additional variable genes.
Results: DNA of six reference strains and 234 clinical isolates from South-Western and Eastern Germany was
subjected to linear amplification and labeling with dUTP-linked biotin. Amplicons were hybridized to microarrays
providing information on the presence of target genes and on their alleles. Tested isolates were assigned to 37
distinct profiles that clustered mainly according to MLST-defined clades. Three additional profiles were predicted
from published genome sequences, although they were not found experimentally.
Conclusions: The microarray based assay allows rapid and high-throughput genotyping of clinical C. difficile isolates
including toxin gene detection and strain assignment. Overall hybridization profiles correlated with MLST-derived clades.
Keywords: Clostridium difficile, DNA-microarray, Molecular typing, Surveillance
Background
Clostridium difficile is a component of the human co-
lonic flora. If the physiological bacterial flora in the
colon is altered or damaged by antibiotics, especially by
clindamycin, fluoroquinolones, cephalosporins, or amoxi-
cillin/clavulanic acid [1, 2], C. difficile is able to multiply
and to cause damage due to its production of several
toxins. Resulting conditions are antibiotic-associated diar-
rhea and pseudomembranous colitis (for a recent review,
see [1]). Severe cases might progress to toxic megacolon
and end fatally [3].
Important virulence factors are secreted toxins TcdA
and TcdB, encoded by genes tcdA and tcdB [4] that
form a pathogenicity locus together with regulatory genes
(tcdC and tcdD) and a gene (tcdE) encoding a holin-like
pore-forming protein [5]. TcdA and TcdB irreversibly
modify GTPases from the Ras superfamily resulting in dis-
ruption of vital signaling pathways of the cell and in cell
death [4]. Besides, some C. difficile strains harbor a binary
toxin encoded by cdtA and cdtB. The binary toxin appears
to modify actin via its ADP-ribosyltransferase activity. Its
clinical significance is not yet fully elucidated [4, 6, 7]
The therapy of C. difficile infection includes rehydration,
discontinuation of antibiotics triggering the condition, oral
administration of vancomycin or metronidazole as well as
surgical intervention in severe cases [1]. Relapses are com-
mon, either due to surviving spores, or to re-infection. A
possible role of probiotics is still investigated as well as the
concept of transplanting feces in order to restore the
physiological flora [8, 9]. With increasing numbers of pa-
tients who receive long-term, broad-spectrum antibiotic
therapies, C. difficile became an increasingly important
problem in healthcare. Case numbers as well as fatality
rates are increasing; with the latter being attributed to the
emergence of more virulent strains [10].
Transmissions of C. difficile and even outbreaks within
hospital settings are common, given that spores are able
to survive in a clinical environment and are resistant to
alcoholic disinfectants [1]. Hospitalizations, or residence
in nursing homes, are significant risk factors for acquisi-
tion of C. difficile, and 50 % of patients who stayed in hos-
pital for more than one month acquired C. difficile [11].
Transmissions within healthcare setting justify infection
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control measures, in analogy to, e.g., methicillin-resistant
S. aureus. Besides barrier nursing, isolation, disinfection,
etc., this also should include molecular typing in order to
trace chains of infections. A variety of methods that in-
cluded multilocus sequence typing (MLST), sequencing of
the slpA gene, multilocus variable-number tandem-repeat
analysis and ribotyping has been described previously
[12–17] and genome sequencing might become an option
in the future.
Microarray-based rapid typing proved to be a conveni-
ent tool for MRSA genotyping [18] allowing both, viru-
lence and resistance gene detection and molecular typing
within one experiment. Therefore, a microarray-based
assay was designed to prove this concept for C. difficile.
Results
Profile- and MLST based clade assignment
Data for a subset of most relevant target genes are pre-
sented in Table 1; full data are provided in the Additional
file 1.
Isolates were clustered into hybridization profiles (HP)
or strains based on overall hybridization profiles with
emphasis to tcdA/B and slpA alleles. Isolates or strains
were regarded as one HP in case of at least 88 % identity
of positive/ambiguous/negative classifications for all
probe positions covered, plus presence of identical tcdA/
B and slpA alleles. Possibly mobile resistance markers were
counted for the score, but they were, contrarily to tcdA/B
and slpA, not considered for the definition of hybridization
profiles or strains. It still needs to be clarified whether these
genes could be used as subtyping markers for isolates
within one HP (i.e., for outbreak investigations).
Applying this approach, tested isolates and reference
strains clustered into 37 distinct hybridization profiles
(HPs; Table 1 and Fig. 1). Three additional profiles were
predicted from published genome sequences, although
they were not found experimentally. If several isolates
with identical hybridization profiles were subjected to
MLST, they yielded identical or related sequence types.
Occasionally, several ribotypes (RTs) were observed
within one cluster and some ribotypes were present in
different, although similar or related, clusters.
In C. difficile, MLST-derived sequence types (STs)
cluster into five major clades [19]. Hybridization profiles
also can be clustered into these clades when analyzing
their similarities (see Fig. 1).
Clade I encompasses a variety of sequence types includ-
ing ST-03, ST-45, ST-54 and others [19]. It was found to
correspond to the largest and most diverse cluster of
hybridization profiles (HP) comprising HP-1 to 30.
Clade II comprised ST-01/RT-027 strains [19]. It
matched hybridization profiles 31 and 32. Beside refer-
ence strains, only two isolates were assigned to this
Clade indicating that the emergence and spread of ST-
01/RT-027 strains [20, 21] did not yet engulf the Dres-
den region at the time when the samples were taken.
Clade III includes ST-05/RT-023 strains [19] corre-
sponding HP-33 and −34. Clade IV consists of ST-37/
RT-017 or HP-35 and -36 strains while a Clade V in-
clude ST-11/RT-078 corresponding to HP-37 to HP-39.
ST-127-like STs might form an additional clade accord-
ing to eBurst analysis (with ST254 as predicted founder),
putatively named “Clade VI” herein. It included the gen-
ome sequence of Strain 6503 (GenBank prefix ADEI)
which translated into a 40th hybridization profile. It was
not identified experimentally.
In the visualization using SplitsTree (see Methods as
well as Fig. 1), the tcdA/B negative isolates appear to
form a separate clade. This, however, can be regarded as
an artifact related to the relatively high number of
probes recognizing the tcd locus (see Discussion).
Alleles of slpA
The gene slpA encodes the surface layer protein. Fifty
four probes were designed to distinguish slpA alleles that
are currently represented in GenBank, with one or two
probes recognizing one allele. Table 2 shows the pre-
dicted patterns and the respective GenBank entries as
well as the corresponding ribotyping and/or MLST data
for isolates identified within this study. The analysis pre-
dicted twenty-eight patterns; twenty-one were found.
Additionally, two patterns were observed which probably
represent truncated variants of known alleles.
Five isolates (2.1 %) yielded no positive slpA signals.
Based on their overall hybridization profiles they clus-
tered into two distinct Clade I strains (HP-06,–30).
However in HP-30, ambiguous signals for one probe
were observed which might indicate the presence of a
truncated variant or divergent allele.
There was no direct correlation of slpA alleles, ribo-
typing and MLST, with isolates of some ribotypes or STs
yielding different slpA alleles.
Alleles of tcdA/tcdB
Four probes allowed distinguishing two tcdA alleles.
Both alleles, tcdAR20291 and tcdACF5, were found in this
study; with the former one being more common and be-
ing detected in more diverse lineages. Table 3 shows cor-
responding GenBank entries, HPs, RTs, MLST types and
slpA types. Nineteen isolates were tcdA-negative.
For tcdB, seven alleles were distinguished using nine
probes (Table 4), but only three, tcdBR20291, tcdB630 and
tcdBCF5, were experimentally identified. Allele tcdB630
was the most common and widespread one. Nineteen
isolates were negative for tcdB; its absence correlated
with the absence of tcdA.
Co-localized genes tcdC and tcdE were interrogated
with one probe each. They were absent from all tcdA/B-
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bcrA630 lmrB630 vatA630 - - - -





bcrA630 lmrB630 vatA630 - (var) (var) -




bcrA630 lmrB630 vatA630 -
HP-05 - - 2 I N/A slpADJNS0578 RT-163 tcdAR20291 tcdB630 cdtA630+
cdtB630
bcrA630 lmrB630 vatA630 - - - -






bcrA630 lmrB630 vatA630 - - - -
HP-07 - - 1 I N/A slpAR12884
trunc.
RT-054 tcdAR20291 tcdB630 cdtA630+
cdtB630
bcrA630 lmrB630 vatA630 - - - -





bcrA630 lmrB630 vatA630 - -




bcrA630 lmrB630 vatA630 - - (var) -
HP-10 - 7 I N/A slpA23m63 N/A tcdAR20291 tcdB630 cdtA630+
cdtB630
bcrA630 lmrB630 vatA630 - - - -
HP-11 CD37*, (AHJJ) 2 I ST-03 slpA23m63 RT-009 - - - bcrA630 lmrB630 vatA630 (var) -
HP-12 - - 2 I N/A slpAJND08162 RT-103 tcdAR20291 tcdB630 cdtA630+
cdtB630
bcrA630 lmrB630 vatA630 - - - -
HP-13 - 70-100-2010*,
(AGAC)




bcrA630 lmrB630 vatA630 - - - -
HP-14 - - 1 I N/A slpAKohn RT-015 tcdAR20291 tcdB630 cdtA630+
cdtB630
bcrA630 lmrB630 vatA630 - - - -
HP-15 - - 1 I N/A slpAKohn N/A - - - bcrA630 lmrB630 vatA630 - - - -
HP-16 - - 2 I N/A slpA79685 RT-029 tcdAR20291 tcdB630 cdtA630+
cdtB630
bcrA630 lmrB630 vatA630 - - - -
HP-17 - - 2 I N/A slpAJND09041 RT-064 tcdAR20291 tcdB630 cdtA630+
cdtB630














Table 1 Detected hybridization pattern types and their association with ribo- and sequence types as well as toxin gene alleles and resistance markers (Continued)
HP-18 - - 7 I ST-17 slpAMRY060211 RT-005 tcdAR20291 tcdB630 cdtA630+
cdtB630
bcrA630 lmrB630 vatA630 - - (var) -




tcdAR20291 tcdB630 - bcrA630 lmrB630 vatA630 - - - -





bcrA630 lmrB630 vatA630 - - - -
HP-21 - - 2 I N/A slpAR13711 RT-031 - - - bcrA630 lmrB630 vatA630 - -
HP-22 - - 1 I N/A slpAR13711 N/A tcdAR20291 tcdB630 cdtA630+
cdtB630
bcrA630 lmrB630 vatA630 - pos pos pos
HP-23 - - 1 I ST-54 slpAR13711 RT-012 tcdAR20291 tcdB630 cdtA630+
cdtB630





18 I ST-54 slpA630 RT-012 tcdAR20291 tcdB630 cdtA630+
cdtB630
bcrA630 lmrB630 vatA630 (var) (var) (var) pos
HP-25 - - 7 I ST-35 slpAJND08037 RT-046 tcdAR20291 tcdB630 - bcrA630 lmrB630 vatA630 pos pos pos pos
HP-26 - - 2 I N/A slpA1446 RT-039 - - - bcrA630 lmrB630 vatA630 - pos pos pos
HP-27 - - 2 I N/A slpAR13700 RT-010 - - - bcrA630 lmrB630 vatA630 - pos - -
HP-28 - Strain 6407*
(ADEH)




slpA6407* N/A tcdACF5* tcdB630* -* bcrA630* lmrB630* vatA630* -* -* -* -*
HP-29 - - 2 I N/A slpA6407 RT-071 - - - bcrA630 lmrB630 vatA630 - - - -

















2 II ST-01* slpAR20291 RT-027 tcdAR20291 tcdBR20291 cdtAR20291
+
cdtBR20291










- II ST-01* slpAR20291* RT-027 tcdAR20291* tcdBR20291* cdtAR20291
+
cdtBR20291
bcrA630* lmrB630* vatA630* -* (var)* - pos*
HP-33 - - 2 III N/A slpAR12884 RT-023 tcdAR20291 tcdB630 cdtAClade
III+
cdtBR20291














Table 1 Detected hybridization pattern types and their association with ribo- and sequence types as well as toxin gene alleles and resistance markers (Continued)
HP-34 - - 1 III N/A slpAR12884
trunc.
N/A tcdAR20291 tcdB630 cdtAClade
III+
cdtBR20291










slpACF5 RT-017 tcdACF5 tcdBCF5 - bcrACF5 lmrB630 vatA630 - (var) (var) pos






8 V ST11 slpAR13540 RT-078 tcdAR20291 tcdB630 cdtAR20291
+
cdtBM120
bcrANAP07 lmrBNAP07 vatANAP07 - (var) (var) -
HP-38 - Strain 6466 *,
(ADDE)
- V ST-11*, (1
mismatch)
slpAR13540* N/A tcdAR20291* tcdB630* cdtAR20291
+
cdtBM120*
bcrANAP07* lmrBNAP07* vatANAP07* -* -* pos* pos*
HP-39 - QCD-23 m63*,
(ABKL)
2 V ST-11*, (1
mismatch)
slpA23m63 N/A tcdAR20291 tcdB630 cdtAR20291
+
cdtBM120
bcrANAP07 lmrBNAP07 vatANAP07 - - - -
HP-40 - Strain 6503*,
(ADEI)
- “VI” ST127 dlv* slpA6503* N/A -* -* -* bcrACF5* lmrB630* vatA630* -* -* -* -*
Full hybridization profiles are provided as Additional file 2














negative strains, but frequently they yielded also in other
isolates negative or ambiguous results. This might be
attributed to sub-optimal binding conditions for these
individual probes, un-appreciated sequence variation or
to a technical problem during probe synthesis, and
should in future be overcome by re-design.
Binary toxin
Two alleles of the A component (cdtAR20291 and cdtA630)
of the Binary Toxin were theoretically predicted from
published sequences as well as experimentally identified
with four different oligonucleotide probes. Isolates of RT-
023/MLST Clade III yielded an additional pattern for
which no matching GenBank entry was identified. It is pu-
tatively named “cdtAClade III” in Tables 1 and 5. For the B
component (cdtB), three alleles (cdtBM120, cdtBR20291 and
cdtB630) were distinguishable with six probes.
The variant cdtA630 + cdtB630 was the most ubiquitous
one in accordance to the predominance of Clade 1, al-
though some isolates completely lacked cdtA/B. In Clade
1 isolates, ambiguous signals were frequently detected
apparently due to a poor performance of two probes (as
discussed above for tcdC and tcdE). Clade II strains har-
bored a distinct variant, cdtAR20291 + cdtBR20291. Isolates
of RT-023 or MLST Clade III yielded “cdtAClade III” while
cdtB signals in these isolates were indistinguishable from
the cdtBR20291 allele. Clade V isolates carried cdtAR20291
and a characteristic cdtB allele, cdtBM120. Finally, no
cdtA/B was detected in Clade IV isolates, and a “Clade
VI” genome sequence (Strain 6503, ADEI) did also not
include these genes.
Ubiquitous resistance markers
The gene bcrA, encoding the bacitracin ATP binding
cassette transporter BcrA, was present in all C. difficile
isolates but four. Three probes could be used to identify
three different alleles.
Allele bcrA630 (GenBank AM180355.1; 767,494 to
768,420;probe 1072) was present in all Clade I and Clade
II isolates. Clade V isolates carried allele bcrANAP07
(GenBank ADVM01000079.1; 10,507 to 11,100;probes
1071 and 1073). Clade IV and VI harbor bcrACF5 (Gen-
Bank FN665652.1; 715,979 to 716,905)which also yielded
a signal with probe 1071 while the binding site of 1073
was more similar to the equivalent site in bcrA630 (differ-
ing in one base from bcrA630 but in five from bcrANAP07).
Three tested Clade III isolates appeared bcrA-negative.
Since no published genome sequence was available for
that clade, it is not clear whether this lineage lacks the
gene entirely, or harbors an unknown allele.
The gene lmrB, associated with lincomycin/clindamy-
cin resistance was detected in all tested isolates, and in
all published genome sequences analyzed. Two probes
were used to identify two different alleles. Allele lmrB630
(GenBank AM180355.1; 2,893,512 to 2,894,912), was
detected in the vast majority of isolates. In isolates associ-
ated with Clade V, another allele, lmrBNAP07 (GenBank
ADVM01000028.1; 28,036 to 29,436) was found.
Fig. 1 SplitsTree graph based on hybridization profiles, showing the clustering of profiles into different clades as defined by MLST. For the issue
of the tcd-negatives, see Discussion.
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Table 2 Alleles of splA, corresponding probes, GenBank entries and typing data






slpA1446 DQ117219.1 probe-1186 + probe-
1201
RT-039 I HP-22
slpA23m63 ABKL02000030.1 AB489091.1 (partial), AB236726.1, AB621540.1,
AB629936.1,





RT-009 I; V ST-03, ST11slv* HP-10, HP-11, HP-39
slpA630 AM180355.1 ADEJ01000377.1, AF448123.1, AF448124.1,




RT-012, RT-137, RT-150 I ST-04, ST-54 HP-04, HP-24




I ST-58 HP-03, HP-28, HP-29
slpA6503 ADEI01000069.1 - probe-1164 + probe-
1197
- “VI” ST-127dlv HP-40
slpA6503
trunc.
- - probe-1164 RT-029, RT-081, RT-094 I ST-09 (HP-30)
slpA79685 AF448371.1/
AB236727.1




RT-017, RT-029 I; IV - HP-16, HP-36
slpAATCC43593 AF458879.1 AF448122.1, AF448121.1 probe-1176 + probe-
1236
- - - -
slpACF5 FN665652.1 AB236153.1, AB236154.1, AB236155.1, AB236156.1,
AB236157.1, AB602320.1, AB704917.1, AB704920.1,





RT-017 IV ST-37, ST-86 HP-35
slpADJNS05008 AB259786.1 - probe-1174 + probe-
1182
- I - -
slpADJNS0578 AB258983.1 - probe-1199 + probe-
1200
RT-163 I - HP-05
slpAHR02 AB236725.1 - probe-1171 + probe-
1237
- - - -
slpAJ9952 AB232929.1 - probe-1175 + probe-
1195
- - - -
slpAJ9952
trunc.
- - probe-1175 RT-013, RT-087 I - HP-19
slpAJND08037 AB465011.2 AB259787.1 probe-1173 + probe-
1243
RT-046 I ST-35 HP-25
slpAJND08162 AB533281.1 AB258978.1, AB258979.1, AB258980.1 probe-1193 + probe-
1202
RT-103 I - HP-12
slpAJND08232 AB621541.1 - probe-1184 + probe-
1211














Table 2 Alleles of splA, corresponding probes, GenBank entries and typing data (Continued)
slpAJND09041 AB602321.1 - probe-1205 + probe-
1206
RT-064 I - HP-17
slpAKohn AF448119.1 - probe-1158 + probe-
1183
RT-015 I - HP-14, HP-15




RT-005 I ST-17 HP-18
slpAOG45 AB231584.1 - probe-1208 - - - -
slpAR12884 DQ060630.1 AF458877.1, AF458878.1, AF478570.1, DQ060631.1,





I; III ST-08 HP-20, HP-33
slpAR12884
trunc.
- - probe-1156 RT-054 I; III - HP-07, HP-34
slpAR12885 DQ060638.1 AB231583.2, AB257281.1, AB257282.1, AB534595.1,
AB534596.1, AB534597.1, AB704918.1, AB704919.1,
AF448365.1, AF448366.1, AF448367.1, AGAC01000036.1,




RT-014, RT-049 I ST-42 HP-13




RT-078 V ST-11 slv HP-37, HP-38
slpAR13541 DQ060628.1 DQ060629.1 AB240196.1; AB257283.1; AB257284.1 (probe-1155) +
probe-1191
RT-002, RT-159 I ST-08 HP-09
slpAR13700 DQ060633.1 AF458880.1, AF458881.1, AF458882.1, AF478571.1 probe-1154 + probe-
1192
RT-010 I HP-27










AB249984.1, AB249985.1, AB257287.1, AB302932.1,
ABHD02000026.1, ABKJ02000019.1, AF448128.1,









slpAR20291 FM160739.1 ABKK02000030.1, AAML04000014.1, AB249986.1,






RT-027 II ST-01 HP-31, HP-32
slpAY5 AB538230.1 GU230472.1, AB269265.1 probe-1180 + probe-
1196
- - - -
splA
negative



















Other GenBank entries Hybridization
pattern






































RT-001, RT-002, RT-005, RT-009,
RT-011, RT-012, RT-013, RT-014,
RT-015, RT-023, RT-027, RT-029,
RT-031, RT-045, RT-046, RT-049,
RT-054, RT-056, RT-057, RT-064,
RT-070, RT-071, RT-072, RT-078,
RT-081, RT-087, RT-094, RT-103,
RT-137, RT-150, RT-159, RT-163







HP-01, HP-02, HP-03, HP-04,
HP-05, HP-06, HP-07, HP-08,
HP-09, HP-10, HP-12, HP-13,
HP-14, HP-16, HP-17, HP-18,
HP-19, HP-20, HP-22, HP-23,
HP-24, HP-25, HP-30, HP-31,
HP-32, HP-33, HP-34, HP-37,
HP-38, HP-39







slpA6407, slpACF5, slpA79685 RT-17 I, IV ST-37, ST-86 HP-28, HP-35, HP-36
tcdA
negative
- - none slpA1446, slpA23m63, slpAR13711,
slpA6407, slpA6503, slpAKohn,
slpAR13700
RT-009, RT-010, RT-011, RT-012,
RT-015, RT-031, RT-039, RT-049,
RT-056, RT-057, RT-070, RT-071,
RT-094
I, ”VI” ST-03, ST-54,
ST-55, ST-58,
ST-127dlv




















Other GenBank entries Hybridization
pattern































RT-001, RT-002, RT-005, RT-009,
RT-011, RT-012, RT-013, RT-014,
RT-015, RT-023, RT-029, RT-031,
RT-045, RT-046, RT-049, RT-054,
RT-056, RT-057, RT-064, RT-070,
RT-071, RT-072, RT-078, RT-081,
RT-087, RT-094, RT-103, RT-137,
RT-150, RT-159, RT-163







HP-01, HP-02, HP-03, HP-04,
HP-05, HP-06, HP-07, HP-08,
HP-09, HP-10, HP-12, HP-13,
HP-14, HP-16, HP-17, HP-18,
HP-19, HP-20, HP-22, HP-23,
HP-24, HP-25, HP-30, HP-33,














slpAR20291 RT-027 II ST-01 HP-31, HP-32







slpACF5, slpA79685 RT-017 IV ST-37, ST-86 HP-35, HP-36





- - - - -














- - - - -
tcdBSE844 HM062511.1 - probe1119+
probe1121+
probe1129














Table 4 Alleles of tcdB, corresponding probes, GenBank entries and typing data (Continued)
tcdB
negative
- - none slpA1446, slpA23m63, slpAR13711,
slpA6407, slpA6503,slpAKohn,
slpAR13700
RT-009, RT-010, RT-011, RT-012,
RT-015, RT-031, RT-039, RT-049,
RT-056, RT-057, RT-070, RT-071,
RT-094
I, ”VI” ST-03, ST-54,
ST-55, ST-58,
ST-127dlv
HP-11, HP-15, HP-21, HP-26,
HP-27, HP-29, HP-40
Note, ADDE01000319.1, ADDE01000337.1, ADEH01001038.1, ADEH01001419.1, ADEH01001594.1, AJ002558.1, AJ294944.1, AY238986.1, AY238987.1, DQ683724.1, X60984.1 were excluded from analysis because these



















































RT-001, RT-002, RT-005, RT-009,
RT-011, RT-012, RT-013, RT-014,
RT-015, RT-029, RT-031, RT-045,
RT-049, RT-054, RT-056, RT-057,
RT-064, RT-070, RT-071, RT-072,









































































slpA23m63, slpAR13540 RT-078 V ST-11 HP-37, HP-38, HP-39
cdtA/B
negative






RT-010, RT-011, RT-012, RT-013,
RT-015, RT-017, RT-029, RT-039,
RT-046, RT-049, RT-056, RT-071,
RT-081, RT-087, RT-094























Likewise, vatA (synonym sat) encoding a virginiamycin/
streptogramin A acetyltransferase was found ubiquitously,
in tested isolates as well as in analyzed genome sequences.
Two alleles were differentiated using two probes, vatA-
NAP07 (GenBank ADVM01000028.1; 23 to 655) in Clade V
isolates and vatA630 (AM180355.1; 2,576,453 to 2,577,085)
in all others.
Variable/mobile resistance markers
The presence of cat (chloramphenicol acetyl transferase),
erm(B) (RNA methyl-transferase, conferring resistance
to macrolides and clindamycin) and tet(M), encoding
tetracycline resistance, was variable. The gene cat was
found in 18 isolates (i.e., in 7.5 % of tested strains and iso-
lates). The gene erm(B) was detected in two reference
strains, BI-9 and 630, as well as in 78 isolates (30 %).
tet(M) was present in two reference strains, M120 and
630, and in 33 isolates (14.6 %). Carriage rates within C.
difficile strains were ranging widely, with isolates of certain
hybridization profiles (e.g., HP-25 to -27) being virtually
always positive for erm(B) and/or tet(M).
For tet(M), five probes reacted in different combina-
tions (Additional file 2). An assignment to alleles was
not performed because of several possible sources for
error. These might include i) a simultaneous presence of
different plasmids in one strain, ii) the existence of
chimeric forms (for instance, 5′-and 3′-ends in
AJ973139.1, AJ973141.1 and FN665653.1 are identical to
ADNX01000070.1 while the middle parts are identical to
AM180355.1) and iii) possible irregular patterns for low-
copy number plasmids with an effective target concentra-
tion around the detection limit of the linear amplification
procedure.
Other markers
Two genes, vncS/vexP1 encoding a histidine kinase and
a permease were found to always occur together. Some
similar strains (e.g., HP-31 and-32, or HP-35 and -36)
could be distinguished by their presence or absence.
Several other markers contributed to specific profile
showing different alleles that were uniform within a HP
but could vary within a clade (Additional file 2). These
included genes encoding septum formation initiation
protein (divC), flagellin subunit C (fliC), cell wall pro-
teins 66 and 84.
Discussion
A rapid, reproducible and convenient method for molecu-
lar typing of C. difficile was developed. It based on a linear
multiplex amplification followed by array hybridization.
Target genes were resistance genes localized in published
C. difficile genome sequences and toxin genes with their
different alleles. In addition to these markers, other genes
were selected based on the variability of their presence
(e.g., vncS/vexP1) or their sequence (divC, fliC, bcrA, lmrB,
vatA, genes encoding cell wall proteins 66 and 84). Alone
these genes would not be suitable typing markers but
taken together, they can be used to generate stable profiles
or fingerprints that allow assignment to clusters or clades
as defined by other methods.
Genes that show clade-specific allelic variations also
include the toxin genes. Therefore, a topic for a future
study could be a possible correlation of toxin alleles
and/or of clonal complex affiliations to clinical severity.
In order to check whether a possible higher virulence is
caused by the actual toxin alleles, or by some other fac-
tor linked to phylogenetic background, a high number of
isolates from defined conditions need to be typed and
their toxin alleles need to be determined. The proposed
system might be a suitable platform for such a task.
It can be assumed that ribotyping, slpA typing, MLST
and array hybridization yield comparable phylogenetic
information, i.e., strains that are recognized as similar/
related by one method will also appear as similar/related
by the other methods. However, there is no complete
correlation. One ribotype might be associated with two
similar array profiles or related MLST types and vice
versa. Single and multilocus typing schemes by design
tend to emphasize subtle differences. Isolates that are
identical belong by definition to the same ST, but single
locus variants, and even those that differ in a single base
exchange are defined to belong to another ST. STs are
numbered chronologically (i.e., by date of submission to
the database curator) so that their numbers yield no
phylogenetic information. Thus, STs with very different
numbers might be still very similar. In order to cluster
related STs, clonal complexes (as in, e.g., Staphylococcus
aureus, [22]) or Clades [19] were introduced giving a
more structured overview on the phylogeny of the target
species. In C. difficile there are five major clades, at least
one minor clade and several “singletons”, i.e., STs that
have no known links to others [19].
When converting HPs to a SplitsTree graph, its top-
ology is strikingly similar to a SplitsTree graph of MLST
sequences as presented by Dingle et al. [19]. The only
significant difference is that all tcdA/B negatives are cat-
egorized as one “branch”. This is an artifact caused by the
high number of probes associated with this locus (n = 15,
out of which nine to ten normally are positive). The loss
of this locus would thus significantly impact the overall
hybridization profile overriding other features affecting a
smaller number of probes. Negative results of other
markers, such as for slpA, would not have this effect be-
cause of the smaller number of probes involved.
With regard to practicalities, a major advantage for the
array-based approach is that isolate typing as well as
toxin gene detection and allele identification can be per-
formed within one experiment by a single amplification
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reaction starting from clonal colony material. The ampli-
fication follows linear kinetics, utilizing one primer per
target. This has the advantage of facilitating unlimited
“multiplexing”, i.e., the simultaneous detection of mul-
tiple targets, and of being resistant to contaminations by
amplicons from previous experiments. The disadvantage
is a reduced sensitivity compared to standard, exponen-
tial PCR. However, since the assay was designed to
characterize cultured and cloned bacterial cultures
(as opposed to native patient samples) this is not of
relevance; and sequencing-based typing methods would
also lead to nonsensical results when applied to polyclonal
samples. In practical terms, protocol and time require-
ments, including hands-on-time, of the linear amplifica-
tion are the same as for normal PCR. The subsequent
hybridization procedure can be performed within half a
day being more rapid than ribotyping. The assay as well as
analysis and interpretation can largely be automatized.
The set of probes can, possibly combined with MLST
markers and splA sequences, also be mapped to “conven-
tional” or “next generation” sequence data in order to rap-
idly obtain clinically relevant typing information out of an
abundance of data and to create a database that encom-
passes both, in silico and in vitro typing data.
Conclusions
The microarray based assay allows rapid and high-
throughput genotyping of clinical C. difficile isolates in-
cluding toxin gene detection and strain assignment.
Overall hybridization profiles correlated with MLST-
derived clades, and target genes that showed clade-
specific allelic variations also included the toxin genes.
Methods
Strains and isolates
Completely sequenced strains 630 (GenBank AM180355),
BI9 (FN668944), CF5 (FN665652), M120 (FN665653),
CD196 (FN538970) and R20291 (FN545816) were used
for protocol development and validation. Besides that, 234
clinical isolates were tested. 147 isolates were collected
2007–2009 at the Institute for Medical Microbiology and
Hygiene Dresden, Germany (IMMHD; serving the Dresden
University Medical Center and a 1000 beds rehabilitation
center nearby). Additionally, 80 isolates were contributed
by the Institute for Medical Microbiology, University
Medical Center Freiburg, Germany and seven by the
Friedrich Loeffler Institute Jena, Germany.
Ethics statement
Isolates were obtained as part of routine diagnostics and
were analyzed retrospectively and anonymously. No pa-
tient data were used. Ethical approval and informed con-
sent were thus not required.
Culture and DNA preparation
Isolates were kept frozen at–80 °C using cryobank tubes
(Microbank, Pro-Lab Diagnostics, Richmond Hill, Canada).
Prior to use they were inoculated on pre-reduced Schaedler
haemin-cysteine blood agar and incubated at 37 °C for
48 hours. Then, harvested culture material was transferred
into 200 μl Lysis buffer/enzyme mix (A1 +A2; from Alere
StaphyType Kit, Alere Technologies, Jena, Germany). After
60 min incubation at 37 °C and 550 rpm, 200 μl AL buffer
and 25 μl Proteinase K (from the QIAamp DNA Mini Kit
Qiagen, Hilden, Germany) were added and another incuba-
tion step of 60 min, at 56 °C and 550 rpm followed. After
addition of ethanol, DNA was purified using spin columns
(QIAamp DNA Mini Kit Qiagen). Finally, DNA was eluted
in 50 μl water and heated for 10 minutes at 85 °C in order
to evaporate trace contaminants of ethanol. The DNA con-
centration was determined spectrophotometrically at
260 nm. If necessary, DNA was concentrated to 150 ng/μl
by evaporation.
Array design
The array was designed to include toxin genes (tcdA/B,
cdtA/B), genes related to antimicrobial resistance (cat,
erm(B), tet(M)), known typing markers (slpA) as well as
genes for which the analysis of published genome se-
quences showed either a variable occurrence, or the occur-
rence of distinct alleles. A complete list of targets and
primer/probe sequences is provided in Additional file 1.
First, all GenBank entries for any given target were re-
trieved. One entry was selected as reference, and its coding
sequence was excised. All resulting BLAST hits were down-
loaded and re-annotated into a local database excising and
aligning all valid open reading frames. Sequences were clas-
sified into paralogues and allelic variants based on similar-
ity. Consensus regions from the alignments were chosen
for the probe and primer design. Probe sequences were se-
lected for specificity and for similar GC content, length,
and melting temperature. Resulting probe sequences were
re-blasted against all available sequences to check for false
negativity or cross-reactivity.
One hundred thirty-five probes were spotted in tripli-
cate on arrays that were mounted into ArrayStrips (http://
alere-technologies.com/en/products/lab-solutions/plat-
form-components/arraystrip-as.html). The length of the
probes ranged from 24 to 34 bases (mean length, 27 bases;
median length, 28 bases). There were 140 primers. Their
lengths ranged from 18 to 25 bases (mean and median
lengths, 20 and 21 bases, respectively).
Protocol optimization
For validation of the array and for the optimization of the
protocol, completely sequenced strains (see above) were
used. Hybridization profiles were predicted by comparing
the probe sequences with their known genome sequences.
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Real hybridization experiments were performed stepwise
modifying hybridization and washing temperatures until
the experiments yielded results that were in accordance to
the theoretical predictions (Additional file 2). The result-
ing protocol is described below.
Linear DNA amplification and labeling
DNA labeling was performed during the linear amplifica-
tion step by incorporating dUTP-linked biotin. The mas-
ter mix consisted of B1 Buffer (3.9 μl/sample; as all buffers
and reagents used herein, unless stated otherwise, taken
from Alere HybPLUS kit, Alere Technologies), B2 Buffer
(0.1 μl/sample) and a primer mix (0.135 μmol/L of each
primer and a total of 1.0 μl/sample). Then, 5 μl of the
DNA preparation was added. The amplification was
carried out using a Mastercycler (Eppendorf GmbH,
Hamburg, Germany) with 5 min of initial denaturation
at 96 °C, followed by 55 cycles (60 sec at 96 °C, 20 sec
at 50 °C and 40 sec at 72 °C).
Hybridization and detection
Prior to use, each array was subsequently incubated with
200 μl double-distilled water and 200 μl C1 washing buf-
fer (both steps at 50 °C, 5 min and 550 rpm on a
BioShake iQ thermomixer; Quantifoil Instruments, Jena,
Germany). Then, the biotin-labeled amplicons and 90 μl
C1 buffer were pipetted onto the array and hybridized
for 60 min at 50 °C and 550 rpm. After removal of the
liquid, two washing steps were performed using 200 μl
buffer C2 for 10 min at 45 °C and 550 rpm. Horseradish-
streptavidin conjugate C3 was diluted 1:100 in C4 buffer;
100 μl was added to the array and incubated for 10 min at
30 °C and 550 rpm. After removal, 200 μl C5 Buffer was
added and incubated (5 min, 30 °C, 550 rpm). Finally
100 μl precipitating dye (D1) was pipetted to the array
and incubated for 10 min at room temperature. After re-
moval of liquids, the array was photographed and auto-
matically analyzed using a ArrayMate reading device
(Alere Technologies). Normalized intensities of the spots
were calculated based on their average intensities and
local background [18, 23]. For each probe, three spots
were spotted and for all further analyses the median of the
spot signals was used.
Breakpoint determination relied on the signal intensities
for the ubiquitous, species-specific markers (bacA1, bcrA,
lmrB, hly3, ydiC, spaE) and the biotin staining control. Be-
cause there are several probes for mutually exclusive
alleles of some of these markers (bcrA, lmrB, spaE), only
those probes that gained raw values above 0.2 were con-
sidered. The median of signals of these species markers
and the biotin control was calculated. Each individual
probe on the array that yielded a signal of more than 2/3 of
the median was considered positive; and signals between 1/
3 and 2/3 of this median were regarded ambiguous. If the
median of the species markers and the biotin marker was
below 0.6 the entire experiment was regarded invalid. If
four or less of these markers gained raw values above 0.2,
the entire experiment was regarded invalid, too.
Full hybridization profiles are provided in Additional
file 2.
SplitsTree
In order to visualize similarities, array hybridization profiles
(as in Additional file 2) were converted into ‘sequences’ in
which each probe position could have a value of ‘positive’,
‘negative’, ‘ambiguous’ or ‘variable’. These ‘sequences’ were
used to construct a tree using SplitsTree vers. 4.12.6 [24]
on default settings (characters transformation, uncorrected
P; distance transformation, Neighbor-Net; and variance, or-
dinary least squares).
Additional typing methods
For representative isolates, Multi Locus Sequence Typ-
ing (MLST) was performed with a 3130 Genetic
Analyzer (Applied Biosystems, Foster City, USA). Primer
sequences and reaction conditions were previously de-
scribed by Griffith et al. [14]. Data analysis was per-
formed using the database accessible under http://
pubmlst.org/cdifficile/. Ribotyping of representative iso-
lates was performed as previously described [13].
Additional typing data are also provided in Additional
file 2.
Additional files
Additional file 1: Probe and primer sequences. (PDF 42 kb)
Additional file 2: Full datasets for all tested strains and isolates.
(PDF 437 kb)
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